Source comparison
Telehealth Clinicians Sermorelin Protocol: Dosing vs Patient Monitoring Comparison
Initial Dose 300mcg subcutaneously at bedtime 200–250mcg subcutaneously at bedtime for first 14 days Lower starting dose reduces GI side effects (nausea, cramping) and allows patients to acclimate to injection routine without overwhelming systemic response Sta
This comparison does not assign a generated winner or score.
- Initial Dose
- 300mcg subcutaneously at bedtime
- 200–250mcg subcutaneously at bedtime for first 14 days
- Lower starting dose reduces GI side effects (nausea, cramping) and allows patients to acclimate to injection routine without overwhelming systemic response
- Start lower in telehealth. Patients can't walk into the clinic for immediate support if side effects are intolerable
- Dose Titration Schedule
- Increase to 500mcg at week 4 based on IGF-1 labs
- Increase to 300–400mcg at week 2 based on patient-reported outcomes; IGF-1 labs at week 8
- Remote patients need faster subjective feedback loops. Waiting 4 weeks for labs delays actionable adjustments
- Patient-reported metrics (sleep quality, recovery) are more useful than delayed lab results for early dose optimization
- Injection Timing
- Administer within 30 minutes of bedtime
- Administer 60–90 minutes before bedtime
- Allows patients to complete injection, clean supplies, and settle into sleep routine without feeling rushed. Reduces injection anxiety
- Telehealth patients need buffer time to troubleshoot injection errors without disrupting sleep onset
- Storage Monitoring
- Verbal reminder during follow-up visit
- Written storage checklist sent at day 3 and day 10
- Patients forget verbal instructions; written checklists with photos of correct refrigerator placement reduce temperature excursion errors by 50%
- Remote prescribing requires redundant written safeguards. Verbal-only fails consistently
- Follow-Up Interval
- 4-week in-office visit
- Week 2 telehealth check-in (video or phone), then week 8 and week 16
- Early check-in catches reconstitution errors, injection timing mistakes, and unrealistic expectations before patient discontinues therapy
- The week-two check-in is the single most valuable intervention in remote peptide protocols. It prevents abandonment